More than 100 patients and donors gathered at the Waldorf Astoria New York hotel on Tuesday, April 28, to learn how the Mount Sinai Health System is improving prostate cancer diagnosis and treatment through a unique, multidisciplinary approach and state-of-the-art technology. Read more
Ketan K. Badani, MD, a renowned expert in robotic surgery for kidney and prostate cancer, has joined the Mount Sinai Health System as Vice Chairman of Urology and Robotic Operations, and Director of the Comprehensive Kidney Cancer Program.
Having completed more than 4,000 robotic kidney and prostate surgeries during his career, Dr. Badani, Professor of Urology at Icahn School of Medicine at Mount Sinai, is considered one of the most experienced specialists in the field. He has authored more than 150 peer-reviewed publications and co-wrote the book Robotic Prostatectomy for Prostate Cancer–Is It for You?
An article in Medpage Today noted “Robot-assisted radical prostatectomy (RARP) led to complication rates, readmission rates, and rates of additional cancer therapy similar to those of conventional surgical prostatectomy, a review of almost 6,000 cases showed.”
“First-year reimbursements were greater for patients undergoing robot assisted compared with open radical prostatectomy.”
“Introduced a decade ago, robot-assisted prostatectomy has become the dominant surgical technique for patients with localized prostate cancer. Investigators in some studies have suggested that robotic prostatectomy has driven the overall prostatectomy rate to a level beyond what would have been expected given current demographic and clinical trends.”
My name is Bill Weinzimmer and I am an advanced prostate cancer survivor. When I was diagnosed 18 years ago, I was told I only had 18 months to live. Thanks to the amazing care I received from Dr. Simon J. Hall at The Mount Sinai Hospital, and the significant changes I made in my life, I am still alive and active 18 years later at 83-years-young. I hope my experiences and tips will provide inspiration to others diagnosed with cancer, as well as to their families.